Literature DB >> 19934250

Patient-reported outcomes in drug safety evaluation.

E Basch.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19934250     DOI： 10.1093/annonc/mdp542

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  14 in total

Review 1.  The value of progression-free survival to patients with advanced-stage cancer.

Authors:  Lesley J Fallowfield; Anne Fleissig
Journal:  Nat Rev Clin Oncol       Date:  2011-10-18       Impact factor: 66.675

2.  Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry.

Authors:  Markus Wallwiener; Felix Heindl; Sara Y Brucker; Florin-Andrei Taran; Andreas Hartkopf; Friedrich Overkamp; Hans-Christian Kolberg; Peyman Hadji; Hans Tesch; Johannes Ettl; Michael P Lux; Claudia Rauh; Simon Blum; Naiba Nabieva; Tobias F Brodkorb; Cornelia Faschingbauer; Hanna Langemann; Carla Schulmeyer; Bernhard Volz; Matthias Rübner; Diana Lüftner; Volkmar Müller; Erik Belleville; Wolfgang Janni; Tanja N Fehm; Diethelm Wallwiener; Thomas Ganslandt; Matthias W Beckmann; Andreas Schneeweiss; Peter A Fasching; Paul Gass
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-08-24       Impact factor: 2.915

3.  Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993).

Authors:  Pamela J Atherton; Kelli N Burger; Charles L Loprinzi; Michelle A Neben Wittich; Robert C Miller; Aminah Jatoi; Jeff A Sloan
Journal:  Support Care Cancer       Date:  2011-09-16       Impact factor: 3.603

Review 4.  Metrics to assess quality of life after management of early-stage lung cancer.

Authors:  Jeff A Sloan
Journal:  Cancer J       Date:  2011 Jan-Feb       Impact factor: 3.360

Review 5.  Web-based patient-reported outcomes in drug safety and risk management: challenges and opportunities?

Authors:  Anjan K Banerjee; Simon Ingate
Journal:  Drug Saf       Date:  2012-06-01       Impact factor: 5.606

6.  Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™).

Authors:  V Hagelstein; I Ortland; A Wilmer; S A Mitchell; U Jaehde
Journal:  Ann Oncol       Date:  2016-09-28       Impact factor: 32.976

7.  Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy.

Authors:  Verena Meraner; Eva-Maria Gamper; Anna Grahmann; Johannes M Giesinger; Petra Wiesbauer; Monika Sztankay; Alain G Zeimet; Barbara Sperner-Unterweger; Bernhard Holzner
Journal:  BMC Cancer       Date:  2012-02-28       Impact factor: 4.430

8.  Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients.

Authors:  Andreas D Hartkopf; Joachim Graf; Elisabeth Simoes; Lucia Keilmann; Nina Sickenberger; Paul Gass; Diethelm Wallwiener; Lina Matthies; Florin-Andrei Taran; Michael P Lux; Stephanie Wallwiener; Eric Belleville; Christof Sohn; Peter A Fasching; Andreas Schneeweiss; Sara Y Brucker; Markus Wallwiener
Journal:  JMIR Cancer       Date:  2017-08-07

9.  Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance.

Authors:  Anjan K Banerjee; Sally Okun; I Ralph Edwards; Paul Wicks; Meredith Y Smith; Stephen J Mayall; Bruno Flamion; Charles Cleeland; Ethan Basch
Journal:  Drug Saf       Date:  2013-12       Impact factor: 5.606

10.  An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma.

Authors:  Amélie Anota; Mathieu Boulin; Sandrine Dabakuyo-Yonli; Patrick Hillon; Jean-Pierre Cercueil; Anne Minello; Jean-Louis Jouve; Xavier Paoletti; Laurent Bedenne; Boris Guiu; Franck Bonnetain
Journal:  BMJ Open       Date:  2016-06-24       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.